Hrt Financial LP Regenxbio Inc. Transaction History

Hrt Financial LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$12.89 - $20.82 $204,022 - $329,538	15,828 New	15,828 $284,000
Q2 2023 Aug 11, 2023	BUY	$17.23 - $21.71 $326,318 - $411,165	18,939 New	18,939 $378,000
Q4 2022 Feb 10, 2023	BUY	$20.4 - $24.73 $748,904 - $907,863	36,711 Added 473.63%	44,462 $1.01 Million
Q3 2022 Nov 14, 2022	BUY	$22.29 - $35.04 $172,769 - $271,595	7,751 New	7,751 $204,000
Q1 2021 May 17, 2021	SELL	$33.61 - $49.95 $231,740 - $344,405	-6,895 Closed	0 $0

Q4 2020 Feb 16, 2021	SELL	$26.52 - $49.35 $676,631 - $1.26 Million	-25,514 Reduced 78.73%	6,895 $312,000
Q3 2020 Nov 13, 2020	BUY	$27.01 - $40.26 $875,367 - $1.3 Million	32,409 New	32,409 $891,000
Q1 2020 May 15, 2020	SELL	$21.5 - $54.2 $178,815 - $450,781	-8,317 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$34.54 - $44.87 $287,269 - $373,183	8,317 New	8,317 $340,000

193

42.1M

80.6K

55.2K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $460M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.